Philips Agreement with German Düren Hospital Marks Expansion of its Next Generation EMR Solution into European Market

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is expanding Tasy, its award-winning next generation EMR solution, into the European market. The introduction is being marked with an agreement signed with KrankenHaus Düren. Together with this German public hospital, Philips will co-design and enterprise wide pilot Tasy. It will give the 450 bed institution that treats 70,000 patients per year an innovative EMR solution to meet the requirements and needs of the current and future local hospital market.

Philips already has a highly successful, leading position in the Latin American EMR market with about a thousand installations at healthcare providers in Brazil and Mexico. Tasy, a Best in KLAS award winner, has helped eight hospitals in Brazil receive EMR Adoption Model Stage 6 certification from HIMSS Analytics, meaning the hospitals are near-paperless and are driving integration, security and analytics to optimize patient care.

Traditional EMRs typically contain standard medical and clinical data about a patient. They were originally designed to use this information for administrative tasks such as billing. Philips Tasy takes a different approach and is developed to streamline workflows and optimize patient care. It offers a single integrated platform and database to enable centralized management of all medical, organizational and administrative processes. These range from patient care to inventory and supply management, revenue cycle management and financial reporting. Other processes Tasy covers are bed management and the scheduling of rooms and the right staff for appointments and medical procedures. It also adds to patient safety by featuring scientifically established protocols and advanced algorithms for rapid detection of sepsis and infections.

"We are excited to enter the European market with an innovative EMR solution that takes a more seamless approach to managing care and solves many of the challenges of traditional solutions," said Yair Briman, Business Leader of Healthcare Informatics at Philips. "The single platform allows for standardization of processes across the hospital with anytime, anywhere access to big data analytics. This will enable advanced real-time risk assessment and decision making, helping to continuously improve safety and patient outcomes."

"In Germany, there is a clear need for a new generation of hospital information management solutions that actively involves patients and supports clinical and administrative decision-making," said Dr. Gereon Blum, CEO of Krankenhaus Düren. "In order to streamline both clinical and non-clinical tasks we need to give everyone access to the same consistent data in real time. A patient-centric solution like Tasy aims to capture data, to aggregate and share relevant patient information, allowing better collaboration and faster coordination among medical professionals, for better and safer patient care within all the medical disciplines."

There is a need for innovative EMR solutions that help hospitals become fully digitized, overcome administrative hurdles and streamline workflows across departments. Hospitals and care networks are dealing with a number of pressing business challenges such as changing population demographics, a growing demand for access to quality care and strained budgets. Advanced interoperability in health information exchange is critical for hospitals dealing with massive amounts of data coming from multiple disparate systems. In order to meet the demand for care while containing healthcare costs, doctors and nursing staff are challenged to work more efficiently and collaboratively across medical disciplines. Physicians often find that traditional EMR and EHRs add significant hours to their work day and interrupt the doctor-patient relationship.

In Germany, Tasy will be implemented as both a web and cloud-based system. It is based on HTML5 and is fully mobile.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 70,000 employees with sales and services in more than 100 countries.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...